TY - JOUR
T1 - Population health outcomes in South Korea 1990–2019, and projections up to 2040
T2 - a systematic analysis for the Global Burden of Disease Study 2019
AU - GBD 2019 South Korea BoD Collaborators
AU - Park, Seoyeon
AU - Kim, Min Seo
AU - Yon, Dong Keon
AU - Lee, Seung Won
AU - Ward, Joseph L.
AU - McLaughlin, Susan A.
AU - Mehlman, Max L.
AU - Koyanagi, Ai
AU - Smith, Lee
AU - Jacob, Louis
AU - Agampodi, Suneth Buddhika
AU - Beiranvand, Maryam
AU - Choi, Dong Woo
AU - Hong, Sung Hwi
AU - Hosseinzadeh, Mehdi
AU - Kim, Cho Il
AU - Kim, Gyu Ri
AU - Kim, Jihee
AU - Kim, Kwanghyun
AU - Kim, Sungroul
AU - Lee, Doo Woong
AU - Lee, Hankil
AU - Lee, Sang Woong
AU - Lee, Yo Han
AU - Mokdad, Ali H.
AU - Murray, Christopher J.L.
AU - Okekunle, Akinkunmi Paul
AU - Park, Eun Cheol
AU - Rabiee, Navid
AU - Shin, Youn Ho
AU - Hay, Simon I.
AU - Shin, Jae Il
N1 - Publisher Copyright:
© 2023 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC BY 4.0 license
PY - 2023/8
Y1 - 2023/8
N2 - Background: South Korea has one of the longest operating universal health coverage (UHC) systems. A comprehensive analysis of long-term trajectories of morbidity and mortality in the South Korean population after the inception of UHC is needed to inform health-care policy and practice. Methods: We used data from the Global Burden of Disease Study (GBD) 2019 to present estimates of cause-specific mortality, incidence, prevalence, years of life lost (YLLs), years of life lived with disability, and disability-adjusted life-years (DALYs) in South Korea from 1990 to 2019. We also examined forecasted estimates of YLLs up to 2040 to investigate likely future changes in disease burden. Finally, we evaluated GBD estimates from seven comparator countries to place disease burden in South Korea within a broader context. Findings: Age-standardised DALYs related to non-communicable diseases (NCDs) decreased by 43·6% (95% uncertainty interval [UI] 39·4–47·9) and mortality by 58·8% (55·9–60·5) from 1990 to 2019. In 2019, the ratio of male to female age-standardised rates of YLLs in South Korea was higher than the global average for 75·9% (22 of 29 diseases) of leading causes, indicating a disproportional disease burden on males in South Korea. Among risk factors, tobacco use accounted for the highest number of 2019 deaths (44 470 [95% UI 37 432–53 989]) in males and high systolic blood pressure for the highest number (21 014 [15 553–26 723]) in females. Among the top ten leading causes of YLLs forecast in South Korea in 2040, nine were NCDs, for both males and females. Interpretation: Our report shows a positive landscape of population health outcomes in South Korea following the establishment of UHC. However, due in part to the effects of population ageing driving up medical expenditures for NCDs, financial pressures and sustainability challenges associated with UHC are pressing concerns. Policy makers should work to tackle population ageing and allocate resources efficiently by prioritising interventions that address the leading causes of death and disability identified in this study. Funding: Bill & Melinda Gates Foundation.
AB - Background: South Korea has one of the longest operating universal health coverage (UHC) systems. A comprehensive analysis of long-term trajectories of morbidity and mortality in the South Korean population after the inception of UHC is needed to inform health-care policy and practice. Methods: We used data from the Global Burden of Disease Study (GBD) 2019 to present estimates of cause-specific mortality, incidence, prevalence, years of life lost (YLLs), years of life lived with disability, and disability-adjusted life-years (DALYs) in South Korea from 1990 to 2019. We also examined forecasted estimates of YLLs up to 2040 to investigate likely future changes in disease burden. Finally, we evaluated GBD estimates from seven comparator countries to place disease burden in South Korea within a broader context. Findings: Age-standardised DALYs related to non-communicable diseases (NCDs) decreased by 43·6% (95% uncertainty interval [UI] 39·4–47·9) and mortality by 58·8% (55·9–60·5) from 1990 to 2019. In 2019, the ratio of male to female age-standardised rates of YLLs in South Korea was higher than the global average for 75·9% (22 of 29 diseases) of leading causes, indicating a disproportional disease burden on males in South Korea. Among risk factors, tobacco use accounted for the highest number of 2019 deaths (44 470 [95% UI 37 432–53 989]) in males and high systolic blood pressure for the highest number (21 014 [15 553–26 723]) in females. Among the top ten leading causes of YLLs forecast in South Korea in 2040, nine were NCDs, for both males and females. Interpretation: Our report shows a positive landscape of population health outcomes in South Korea following the establishment of UHC. However, due in part to the effects of population ageing driving up medical expenditures for NCDs, financial pressures and sustainability challenges associated with UHC are pressing concerns. Policy makers should work to tackle population ageing and allocate resources efficiently by prioritising interventions that address the leading causes of death and disability identified in this study. Funding: Bill & Melinda Gates Foundation.
UR - https://www.scopus.com/pages/publications/85166024763
U2 - 10.1016/S2468-2667(23)00122-6
DO - 10.1016/S2468-2667(23)00122-6
M3 - Article
C2 - 37516480
AN - SCOPUS:85166024763
SN - 2468-2667
VL - 8
SP - e639-e650
JO - The Lancet Public Health
JF - The Lancet Public Health
IS - 8
ER -